Lite Strategy, Inc.

Pharmaceutical company · San Diego, California, United States · Nasdaq: LITS

Lite Strategy, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker LITS. It has reported private securities offerings to the US SEC, most recently $75 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Lite Strategy at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Stock listingNasdaq: LITS
SEC industryPharmaceutical Preparations
SEC CIK1262104

What does Lite Strategy do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $75 million sold (2018).

Frequently asked questions about Lite Strategy

Where is Lite Strategy headquartered?

Lite Strategy, Inc. is headquartered in San Diego, California, United States.

What does Lite Strategy do?

Lite Strategy, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Lite Strategy a public company?

Yes. Lite Strategy, Inc. trades on Nasdaq under the ticker LITS.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.